Global Erythropoietin (EPO) Market Outlook 2016-2021

Published: Nov, 2016 | Pages: 129 | Publisher: Gen Consulting Company
Industry: Biotechnology | Report Format: Electronic (PDF)

Erythropoietin, also known as EPO, hematopoietin, or hemopoietin, is a glycoprotein hormone that controls erythropoiesis, or red blood cell production. It is a cytokine (protein signaling molecule) for erythrocyte (red blood cell) precursors in the bone marrow. Human EPO has a molecular weight of 34 kDa.

Erythropoietin is produced by interstitial fibroblasts in the kidney in close association with peritubular capillary and proximal convoluted tubule. It is also produced in perisinusoidal cells in the liver. While liver production predominates in the fetal and perinatal period, renal production is predominant during adulthood.

Exogenous erythropoietin can be provided to people whose kidneys cannot make enough. Recombinant human erythropoietin (rhEPO) is produced by recombinant DNA technology in cell culture. Several different pharmaceutical agents are available with a variety of glycosylation patterns and are collectively called erythropoiesis-stimulating agents (ESA). Major examples are epoetin alfa and epoetin beta. The specific details for labeled use vary between the package inserts, but ESAs have been used in the treatment of anemia in chronic kidney disease, anemia in myelodysplasia, and in anemia from cancer chemotherapy. Boxed warnings include a risk of death, myocardial infarction, stroke, venous thromboembolism, and tumor recurrence. rhEPO has been used illicitly as a performance-enhancing drug; it can often be detected in blood, due to slight differences from the endogenous protein, for example, in features of posttranslational modification.

This report provides detailed analysis of worldwide markets for Erythropoietin (EPO) from 2011-2015 and provides extensive market forecasts 2016-2021 by region/country and subsectors. It covers the key technological and market trends in the Erythropoietin (EPO) market and further lays out an analysis of the factors influencing the supply/demand for Erythropoietin (EPO), and the opportunities/challenges faced by industry participants. It also acts as an essential tool to companies active across the value chain and to the new entrants by enabling them to capitalize the opportunities and develop business strategies.

GCC's report, Global Erythropoietin (EPO) Market Outlook 2016-2021, has been prepared based on the synthesis, analysis, and interpretation of information about the global Erythropoietin (EPO) market collected from specialized sources. The report covers key technological developments in the recent times and profiles leading players in the market and analyzes their key strategies. The competitive landscape section of the report provides a clear insight into the market share analysis of key industry players. The major players in the global Erythropoietin (EPO) market are Amgen (USA), Johnson & Johnson (USA), Roche (Switzerland), Kyowa Hakko Kirin (Japan), 3SBIO (China), among others.

The report provides separate comprehensive analytics for the North America, Europe, Asia-Pacific, Middle East and Africa and Rest of World. In this sector, global competitive landscape and supply/demand pattern of Erythropoietin (EPO) industry has been provided.

 Table of Contents
Part 1. Exclusive Summary

Part 2. Methodology
2.1 Research Methodology
2.2 Geographic Scope
2.3 Years Considered

Part 3. Introduction
3.1 Definition
3.2 Supply Chain Structure
3.2.1 Raw Material Supply
3.2.2 Traders & Distributors
3.2.3 Key Customers
3.3 Manufacture
3.3.1 Manufacturing Process
3.3.2 Production Cost

Part 4. Market Landscape
4.1 Global Erythropoietin (EPO) Market Size (Volume) 2011-2016
4.1.1 Overview
4.1.2 Global Erythropoietin (EPO) Production
4.1.3 Top 10 Erythropoietin (EPO) Companies (Volume Share)
4.2 Global Erythropoietin (EPO) Market Size (Value) 2011-2016
4.2.1 Overview
4.2.2 Global Erythropoietin (EPO) Production Value
4.2.3 Top 10 Erythropoietin (EPO) Companies (Revenue Share)

Part 5. Segmentation by Products
5.1 Type 1
5.2 Type 2
5.3 Type 3

Part 6. Segmentation by End-users
6.1 Customer Segment 1
6.2 Customer Segment 2
6.3 Customer Segment 3
6.4 Customer Segment 4

Part 7. Geographical Segmentation
7.1 North America Erythropoietin (EPO) Market
7.1.1 North America Market Overview
7.1.2 North America Price & Margin
7.1.3 North America Trade Balance
7.2 EMEA Erythropoietin (EPO) Market
7.2.1 EMEA Market Overview
7.2.2 EMEA Price & Margin
7.2.3 EMEA Trade Balance
7.3 Asia Pacific Erythropoietin (EPO) Market
7.3.1 Asia Pacific Market Overview
7.3.2 Asia Pacific Price & Margin
7.3.3 Asia Pacific Trade Balance

Part 8. Market Forecast
8.1 Market Size by Volume 2016-2021
8.1.1 North America
8.1.2 EMEA
8.1.3 Asia-Pacific
8.1.4 RoW
8.2 Market Size by Value 2016-2021
8.2.1 North America
8.2.2 EMEA
8.2.3 Asia-Pacific
8.2.4 RoW
8.3 Regional Consumption Forecast
8.3.1 North America
8.3.2 EMEA
8.3.3 Asia-Pacific
8.3.4 RoW
8.4 Consumption Forecast by End-users
8.5 Consumption Forecast by Products

Part 9. Company Profiles
9.1 Company A
9.1.1 Overview
9.1.2 Products Offered
9.1.3 Business Performance
9.2 Company B
9.3 Company C
9.4 Company D

Part 10. Market Dynamics
10.1 Market Drivers
10.2 Market Constraints
10.3 Market Strategies

Part 11. Competitive Landscape
11.1 Mergers & Acquisitions
11.2 New Product Launches
11.3 Expansions
11.4 Other Developments

Part 12. Appendix
Disclaimer
Analysts Certification
List of Tables and Figures

Figure Global Production 2011-2016
Figure Global Production Value (M USD) 2011-2016
Figure Top 10 Players Revenue Share 2015
Figure Regional Production 2015
Figure Regional Production Value (M USD) 2015
Figure Global Consumption by End Market 2015
Figure Erythropoietin (EPO) Product
Figure Supply Chain Structure of Erythropoietin (EPO)
Table Raw Materials Used for Erythropoietin (EPO) Production
Table Traders & Distributors of Erythropoietin (EPO)
Table Key Customers of Erythropoietin (EPO)
Figure Erythropoietin (EPO) Manufacturing Process Flow
Figure Erythropoietin (EPO) Production Cost Structure
Figure Global Erythropoietin (EPO) Market, Growth Rate
Table Global Key Vendors Production 2011-2016
Table Global Key Vendors Production Market Share 2011-2016
Figure Global Production, Capacity Utilization 2011-2016
Figure Top 10 Companies Market Share Trends
Table Global Top 10 Vendors Production 2011
Table Global Top 10 Vendors Production 2012
Table Global Top 10 Vendors Production 2013
Table Global Top 10 Vendors Production 2014
Table Global Top 10 Vendors Production 2015
Table Global Top 10 Vendors Production 2016
Figure Global Erythropoietin (EPO) Market (M USD), Growth Rate & CAGR
Table Global Key Vendors Production Value (M USD) 2011-2016
Table Global Key Vendors Production Value Market Share 2011-2016
Figure Top 10 Player Market Share Trends
Table Global Top 10 Vendors Production Value (M USD) 2011
Table Global Top 10 Vendors Production Value (M USD) 2012
Table Global Top 10 Vendors Production Value (M USD) 2013
Table Global Top 10 Vendors Production Value (M USD) 2014
Table Global Top 10 Vendors Production Value (M USD) 2015
Table Global Top 10 Vendors Production Value (M USD) 2016
Figure Prices of Major Players 2016
Figure Gross Margin of Major Players 2016
Table Types of Erythropoietin (EPO)
Figure Global Production Market Share of Erythropoietin (EPO) by Types in 2015
Table Type 1 Erythropoietin (EPO) Production 2011-2016
Table Type 1 Erythropoietin (EPO) Price Trends 2011-2016
Table Major Manufacturers of Type 1 Erythropoietin (EPO)
Table Type 2 Erythropoietin (EPO) Production 2011-2016
Table Type 2 Erythropoietin (EPO) Price Trends 2011-2016
Table Major Manufacturers of Type 2 Erythropoietin (EPO)
Table Type 3 Erythropoietin (EPO) Production 2011-2016
Table Type 3 Erythropoietin (EPO) Price Trends 2011-2016
Table Major Manufacturers of Type 3 Erythropoietin (EPO)
Figure Global Erythropoietin (EPO) Market by Key Customer Segments 2015
Table Erythropoietin (EPO) Consumed for Customer Segment 1
Table Key Customers of Erythropoietin (EPO)
Table Erythropoietin (EPO) Consumed for Customer Segment 2
Table Key Customers of Erythropoietin (EPO)
Table Erythropoietin (EPO) Consumed for Customer Segment 3
Table Key Customers of Erythropoietin (EPO)
Figure Global Erythropoietin (EPO) Market Segmentation by Geography 2015
Figure North America Erythropoietin (EPO) Capacity & Production 2011-2016
Figure North America Erythropoietin (EPO) Revenue (M USD) 2011-2016
Figure North America Erythropoietin (EPO) Price & Margin 2011-2016
Table North America Erythropoietin (EPO) Trade Balance
Figure North America Erythropoietin (EPO) Self-sufficiency
Figure EMEA Erythropoietin (EPO) Capacity & Production 2011-2016
Figure EMEA Erythropoietin (EPO) Revenue (M USD) 2011-2016
Figure EMEA Erythropoietin (EPO) Price & Margin 2011-2016
Table EMEA Erythropoietin (EPO) Trade Balance
Figure EMEA Erythropoietin (EPO) Self-sufficiency
Figure Asia Pacific Erythropoietin (EPO) Capacity & Production 2011-2016
Figure Asia Pacific Erythropoietin (EPO) Revenue (M USD) 2011-2016
Figure Asia Pacific Erythropoietin (EPO) Price & Margin 2011-2016
Table Asia Pacific Erythropoietin (EPO) Trade Balance
Figure Asia Pacific Erythropoietin (EPO) Self-sufficiency
Figure Global Production Volume Forecast 2016-2021
Table Global Production Volume 2016-2021
Table Global Production Volume Share 2016-2021
Figure North America Erythropoietin (EPO) Production Volume Forecast
Figure Global Production Value (M USD) 2016-2021
Table Global Production Value (M USD) 2016-2021
Table Global Production Value Share 2016-2021
Figure North America Erythropoietin (EPO) Production Value (M USD) Forecast
Figure Regional Consumption 2021
Table Consumption Volume by Region 2016-2021
Table Consumption Volume Share by Region 2016-2021
Figure North America Consumption 2016-2021
Figure Consumption by Key Customer Segments 2021
Table Global Erythropoietin (EPO) Market by Customer Segments 2016-2021 (Volume)
Table Global Erythropoietin (EPO) Market by Customer Segments 2016-2021 (Share)
Figure Consumption by Types 2021
Table Global Consumption Volume by Types 2016-2021
Table Global Consumption Volume Share by Types 2016-2021
Table Financial Performance 2011-2016
Figure Market Share Trend 2011-2016